Daewon Pharmaceutical Co., Ltd.

This early-stage trial tests the safety and how the body processes two experimental drugs (DW4421-T1 and DW4421S-T1) in 38 healthy adults aged 19 to 50. Participants receive a single dose of each drug in a random order, and researchers measure drug levels and monitor for side eff…

This early-stage trial will test how a new drug called DW4421 interacts with two common antibiotics (amoxicillin and clarithromycin) in 36 healthy adults aged 19 to 50. The study measures safety and how the drugs move through the body. It does not aim to treat any disease.

This early-stage study will test the safety of a new drug, DW5524, in 48 healthy adults. Participants will receive a single dose of the drug, and researchers will monitor how the body processes it and if any side effects occur. The goal is to gather basic safety information befor…